Nephros wins FDA nod for chronic renal failure device

The FDA has granted Nephros 510(k) clearance for its Hemodiafiltration system, which is used to help treat patients with chronic renal failure. The device features the company's OLpur MD220 Hemodiafilter and OLpur H2H Hemodiafiltration module.

View Full Article in:

Nephros, Inc. Receives 510(k) Clearance for Hemodiafiltration System - Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX